Villa delle Ginestre
- Address
- Via Castellana 145, 90135 Palermo, Italy
Villa delle Ginestre - Neurodegenerative Disease Research Center
Villa delle Ginestre is a specialized medical research facility dedicated to advancing treatments for progressive neurodegenerative disorders. The center conducts rigorous clinical trials focused on amyotrophic lateral sclerosis (ALS), investigating novel therapeutic interventions aimed at slowing disease progression and preserving patient functionality.
- Amyotrophic Lateral Sclerosis (ALS) treatment development and neuroprotective therapies
- Assessment of metabolic interventions including acetyl-L-carnitine for motor neuron diseases
- Functional disability progression monitoring using validated clinical scales
The center's research program emphasizes the evaluation of biological and clinical effects of emerging therapeutics through randomized controlled trials. With particular expertise in measuring functional disability progression and patient self-sufficiency outcomes, Villa delle Ginestre contributes valuable data to the global effort to identify effective treatments for neurodegenerative conditions that currently have limited therapeutic options.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Villa delle Ginestre
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Randomized Phase II/III Trial Evaluating Acetylcarnitine Hydrochloride on Functional Disability Progression in Amyotrophic Lateral Sclerosis Patients | Istituto Di Ricerche Farmacologiche Mario Negri | Phase IV | Recruiting | Feb 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| ACETYLCARNITINE HYDROCHLORIDE | 1 | Unknown | 2025-02-24 | 2025-02-24 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.